My watch list
my.bionity.com  
Login  
NEWS
Current news

Next step on the path towards an efficient biofuel cell

Two concepts combined making system as efficient as precious metal catalysts

16-Nov-2018 Fuel cells that work with the enzyme hydrogenase are, in principle, just as efficient as those that contain the expensive precious metal platinum as a catalyst. However, the enzymes need an aqueous environment, which makes it difficult for the starting material for the reaction – hydrogen – ... more

Insect Antibiotic Provides New Way to Eliminate Bacteria

16-Nov-2018 An antibiotic called thanatin attacks the way the outer membrane of Gram-negative bacteria is built. Researchers at the University of Zurich have now found out that this happens through a previously unknown mechanism. Thanatin, produced naturally by the spined soldier bug, can therefore be ... more

Carbon fibers from greenhouse gas

How algae could sustainably reduce the carbon dioxide concentration in the atmosphere

16-Nov-2018 In collaboration with fellow researchers, chemists at the Technical University of Munich (TUM) have developed a process that, according to initial calculations, can facilitate economically removing the greenhouse gas carbon dioxide from the atmosphere. The latest World Climate Report (IPCC ... more

Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

Life Science company to develop cancer targeted radiopharmaceuticals

16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

Moths and magnets could save lives

Experimental therapy could repair mutations that cause genetic diseases

15-Nov-2018 A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis. Rice University bioengineer Gang Bao has combined magnetic nanoparticles with a viral container d ... more

"Waltzing" nanoparticles could advance search for better drug delivery methods

"Swirling and spinning" of therapeutic nanoparticles

15-Nov-2018 Indiana University researchers have discovered that drug-delivering nanoparticles attach to their targets differently based upon their position when they meet -- like ballroom dancers who change their moves with the music. The study is significant since the "movement" of therapeutic particl ... more

Grünenthal acquires Averitas Pharma and establishes commercial footprint in the US

15-Nov-2018 Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza® (8 % capsaicin) for Grünenthal in the US. Grünenthal had only ... more

Merck has a good third quarter

Strong organic sales growth impacted by negative exchange rate effects

14-Nov-2018 Merck generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects. Despite organic growth, EBITDA pre of the Group also declined in comparison with the year-earlier quarter owing to strong negative foreign exchange ef ... more

Stealth-cap technology for light-emitting nanoparticles

14-Nov-2018 A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles. The team has developed the ... more

First microarrayed 3D neuronal culture platform developed

14-Nov-2018 Neuronal development is often regulated by the graded distribution of guidance molecules, which can either attract or repel the neuronal migration or neurite projection when presented in a format of concentration gradients, or chemotaxis. However, many details about the process is largely u ... more

All news

A Chip with Blood Vessels

14-Nov-2018 Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way. Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, ... more

Half a needle in a haystack

New method rapidly detects trace amounts of small molecule compounds

07-Nov-2018 Russian researchers from Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS) and the Moscow Institute of Physics and Technology (MIPT) have developed the world’s first ultrasensitive method for rapid detection of small molecules. This method detects trace amount ... more

Unraveling a genetic network linked to autism

06-Nov-2018 Donnelly Centre researchers have uncovered a genetic network linked to autism. The findings will facilitate developing new therapies for this common neurological disorder. As part of a collaborative research program focusing on autism led by Benjamin Blencowe, a professor in the University ... more

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

05-Nov-2018 Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction. This price represents a premium of 71% to Pacific Biosciences’ 30 trading day volume weigh ... more

Eurofins scientific acquires two North American companies

02-Nov-2018 By acquiring EnvironeX Group Inc. in Canada and TestAmerica in the USA Eurofins expands its testing capabilities in the North American market. EnvironeX Group Inc. - bioanalytical testing in Canada Founded in 2005 by Marc Hamilton and supported by PCP since 2015, EnvironeX is a leading prov ... more

New technique enables spatial separation of peptide structures

Milestone on the way to direct imaging of individual biomolecules

01-Nov-2018 A team of scientists at DESY and Universität Hamburg has reached another milestone towards the direct imaging of individual biomolecules: the group led by Jochen Küpper from the Center for Free-Electron Laser Science developed a new experimental technique which enables the separation of dif ... more

analytica Vietnam records exhibitor rush

29-Oct-2018 About half a year before the start of analytica Vietnam, the trade fair for laboratory technology, analysis, biotechnology and diagnostics in Ho Chi Minh City is in greater demand than ever before. Now, by the end of Octo-ber, about 60 percent more exhibitors than in the same period of 2016 ... more

Anti-aging molecule NAD+ gets a boost from blocking an enzyme

25-Oct-2018 Nicotinamide adenine dinucleotide (NAD+) is a major player in nutrition today. Studies have shown that NAD+ concentrations decrease during aging and that recovering the body's levels of NAD+ can prolong both health span and even life span, making it the focus of much research in nutritional ... more

Expanding the optogenetics toolkit

22-Oct-2018 Controlling individual brain cells using light-sensitive proteins has proven to be a powerful tool for probing the brain's complexities. As this branch of neuroscience has expanded, so has the demand for a diverse palette of protein tools. A multidisciplinary team of 14 researchers from the ... more

Merck sells its Flow Cytometry unit for €62.5 million

19-Oct-2018 Merck announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million. The closing of the transaction, expected by the end of 2018, is subject to customary closing conditions. Upon completion of the transaction, Luminex will own the f ... more

All news on bioanalytics

Next step on the path towards an efficient biofuel cell

Two concepts combined making system as efficient as precious metal catalysts

16-Nov-2018 Fuel cells that work with the enzyme hydrogenase are, in principle, just as efficient as those that contain the expensive precious metal platinum as a catalyst. However, the enzymes need an aqueous environment, which makes it difficult for the starting material for the reaction – hydrogen – ... more

Carbon fibers from greenhouse gas

How algae could sustainably reduce the carbon dioxide concentration in the atmosphere

16-Nov-2018 In collaboration with fellow researchers, chemists at the Technical University of Munich (TUM) have developed a process that, according to initial calculations, can facilitate economically removing the greenhouse gas carbon dioxide from the atmosphere. The latest World Climate Report (IPCC ... more

Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

Life Science company to develop cancer targeted radiopharmaceuticals

16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

Moths and magnets could save lives

Experimental therapy could repair mutations that cause genetic diseases

15-Nov-2018 A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis. Rice University bioengineer Gang Bao has combined magnetic nanoparticles with a viral container d ... more

"Waltzing" nanoparticles could advance search for better drug delivery methods

"Swirling and spinning" of therapeutic nanoparticles

15-Nov-2018 Indiana University researchers have discovered that drug-delivering nanoparticles attach to their targets differently based upon their position when they meet -- like ballroom dancers who change their moves with the music. The study is significant since the "movement" of therapeutic particl ... more

Merck has a good third quarter

Strong organic sales growth impacted by negative exchange rate effects

14-Nov-2018 Merck generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects. Despite organic growth, EBITDA pre of the Group also declined in comparison with the year-earlier quarter owing to strong negative foreign exchange ef ... more

Stealth-cap technology for light-emitting nanoparticles

14-Nov-2018 A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles. The team has developed the ... more

First microarrayed 3D neuronal culture platform developed

14-Nov-2018 Neuronal development is often regulated by the graded distribution of guidance molecules, which can either attract or repel the neuronal migration or neurite projection when presented in a format of concentration gradients, or chemotaxis. However, many details about the process is largely u ... more

T3 Pharmaceuticals wins prestigious Falling Walls Venture Award

13-Nov-2018 T3 Pharma, a biotech start-up company of the University of Basel with a focus on immuno-oncology, has been named “2018 Science Start-Up of the Year” by Falling Walls Venture. The award honors the scientist-entrepreneurs for their breakthrough business model in bacterial cancer therapy. The ... more

Merck Paves the Way for its Innovation Hub in Southern China

Company signed agreement with Guangzhou Development District

12-Nov-2018 Merck signed an agreement with the Guangzhou Development District on innovation development in Southern China. Pursuant to this agreement, Merck will establish an innovation hub in Guangzhou scheduled to open September 2019. “China is a major innovation hotspot and one of our most important ... more

All news on biotechnology

Merck has a good third quarter

Strong organic sales growth impacted by negative exchange rate effects

14-Nov-2018 Merck generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects. Despite organic growth, EBITDA pre of the Group also declined in comparison with the year-earlier quarter owing to strong negative foreign exchange ef ... more

Stealth-cap technology for light-emitting nanoparticles

14-Nov-2018 A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles. The team has developed the ... more

Poxvirus hijacks cell movement to spread infection

13-Nov-2018 Vaccinia virus, a poxvirus closely related to smallpox and monkeypox, tricks cells it has infected into activating their own cell movement mechanism to rapidly spread the virus in cells and mice, according to a new UCL-led study. The findings explain how the virus mimics infected cells' own ... more

Nano-scale process may speed arrival of cheaper hi-tech products

12-Nov-2018 An inexpensive way to make products incorporating nanoparticles - such as high-performance energy devices or sophisticated diagnostic tests - has been developed by researchers. The process could speed the commercial development of devices, materials and technologies that exploit the physica ... more

New flexible, transparent, wearable biopatch, improves cellular observation, drug delivery

Minimally invasive patch delivers exact doses directly into cells, lessens pain, toxicity

12-Nov-2018 Purdue University researchers have developed a new flexible and translucent base for silicon nanoneedle patches to deliver exact doses of biomolecules directly into cells and expand observational opportunities."This means that eight or nine silicon nanoneedles can be injected into a single ... more

Novel quantum dots enhance cell imaging

31-Oct-2018 A team of researchers from the University of Illinois at Urbana-Champaign and Mayo Clinic have engineered a new type of molecular probe that can measure and count RNA in cells and tissue without organic dyes. The probe is based on the conventional fluorescence in situ hybridization (FISH) t ... more

3D 'organ on a chip' could accelerate search for new disease treatments

30-Oct-2018 Researchers have developed a three-dimensional 'organ on a chip' which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research. The device, which incorporates cells inside a 3D transistor ... more

analytica Vietnam records exhibitor rush

29-Oct-2018 About half a year before the start of analytica Vietnam, the trade fair for laboratory technology, analysis, biotechnology and diagnostics in Ho Chi Minh City is in greater demand than ever before. Now, by the end of Octo-ber, about 60 percent more exhibitors than in the same period of 2016 ... more

Amgen Invests $66 Million In Oxford Nanopore Technologies

24-Oct-2018 Amgen and Oxford Nanopore Technologies Ltd. announced Amgen's equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology. Oxford Nanopore has developed and brought to ... more

Unmasking blood doping in athletes

RNA changes mark old blood cells among new ones, foiling self-transfusions

22-Oct-2018 A Duke University research team has found a way to help sporting officials detect whether an athlete's blood has been doped by an infusion of their own stored blood. While tests have been developed to detect two of the three most common methods of dramatically boosting the oxygen-carrying c ... more

All news on diagnostics

analytica Vietnam records exhibitor rush

29-Oct-2018 About half a year before the start of analytica Vietnam, the trade fair for laboratory technology, analysis, biotechnology and diagnostics in Ho Chi Minh City is in greater demand than ever before. Now, by the end of Octo-ber, about 60 percent more exhibitors than in the same period of 2016 ... more

Sartorius continues to grow by double digits

Growth dynamics of the Lab Products & Services Division impacted by softer European demand

24-Oct-2018 Sartorius continued on the growth track, with double-digit gains in sales revenue and earnings. “In the first nine months of 2018, Sartorius achieved excellent organic growth,” said Dr. Joachim Kreuzburg, Chief Executive Officer. “This applies particularly to the Bioprocess Solutions Divisi ... more

Miltenyi Biotec acquires microscopy specialist

18-Oct-2018 Miltenyi Biotec GmbH announced that it has acquired the high-end microscopy specialist LaVision BioTec GmbH. Located in Bielefeld, Germany, LaVision BioTec is a leading global specialist for advanced light-sheet and multiphoton microscopy solutions for life science applications. Since its f ... more

Liver-on-a-chip, the ideal test environment for CRISPR

16-Oct-2018 Two Arizona State University professors are among the first recipients ofSomatic Cell Genome Editing (SCGE) grants from the National Institutes of Health Common Fund. The $2,600,000, five-year grant will fund the first study of the genome editing technology CRISPR to be used on a "human liv ... more

Wyatt acquires german FFF manufacturer Superon

Business units to be relocated to California

16-Oct-2018 Wyatt Technology announced that it has completed the acquisition of Superon GmbH, a manufacturer of Field Flow Fractionation (FFF) systems. Production, research and product development has been transferred to Wyatt’s Santa Barbara, CA headquarters which will enable the company to further en ... more

SOPAT GmbH and Malvern Panalytical announce a distribution agreement for US market

09-Oct-2018 SOPAT GmbH announced a distribution agreement with Malvern Panalytical. Malvern Panalytical is now the exclusive distributor for a complete range of SOPAT photo-optical image analysis instrumentation and software in the United States of America. “We are thrilled to be working together with ... more

New method measures single molecules from nanoliter of blood in real time

09-Oct-2018 University of Groningen scientists, led by Associate Professor of Chemical Biology Giovanni Maglia, have designed a nanopore system that is capable of measuring different metabolites simultaneously in a variety of biological fluids, all in a matter of seconds. The electrical output signal i ... more

Agilent Expands Portfolio in Cell Analysis

02-Oct-2018 Agilent Technologies Inc. announced it has signed a definitive agreement to acquire privately-owned ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis instruments for life science research and clinical diagnostics, for $250 million in cash. “Expanding our cell analysis ... more

Over 600 Partnering discussions at the first European Chemistry Partnering Summer Summit

Industry ratio of participants over 70 %

27-Sep-2018 The first ECP Summer Summit ended today with an international get-together at the headquarters of the consumer and industrial goods company Henkel. 250 participants from 16 nations came together to exchange ideas on innovation across many disciplines: Over 600 partnering discussions took pl ... more

LABVOLUTION AWARD to honor outstanding advances in lab technology

29-Aug-2018 There is no shortage of new initiatives, ideas and projects aimed at making laboratories run more smoothly. Keeping lab samples cool in storage while saving as much energy as possible, finding the best cleaning solution for maintaining the cleanliness of laboratory glassware, devising more ... more

All news on lab technology

Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

Life Science company to develop cancer targeted radiopharmaceuticals

16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

Moths and magnets could save lives

Experimental therapy could repair mutations that cause genetic diseases

15-Nov-2018 A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis. Rice University bioengineer Gang Bao has combined magnetic nanoparticles with a viral container d ... more

"Waltzing" nanoparticles could advance search for better drug delivery methods

"Swirling and spinning" of therapeutic nanoparticles

15-Nov-2018 Indiana University researchers have discovered that drug-delivering nanoparticles attach to their targets differently based upon their position when they meet -- like ballroom dancers who change their moves with the music. The study is significant since the "movement" of therapeutic particl ... more

Grünenthal acquires Averitas Pharma and establishes commercial footprint in the US

15-Nov-2018 Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza® (8 % capsaicin) for Grünenthal in the US. Grünenthal had only ... more

Merck Paves the Way for its Innovation Hub in Southern China

Company signed agreement with Guangzhou Development District

12-Nov-2018 Merck signed an agreement with the Guangzhou Development District on innovation development in Southern China. Pursuant to this agreement, Merck will establish an innovation hub in Guangzhou scheduled to open September 2019. “China is a major innovation hotspot and one of our most important ... more

How to produce fluorescent nanoparticles for medical applications in a nuclear reactor

12-Nov-2018 Under the leadership of Petr Cígler from the Institute of Organic Chemistry and Biochemistry (IOCB Prague) and Martin Hrubý from the Institute of Macromolecular Chemistry (IMC), both of which are part of the Czech Academy of Sciences, a team of researchers has developed a revolutionary meth ... more

Eisai commences full-scale operation of new production site

Strengthening in-house domestic production system in China

09-Nov-2018 Eisai Co., Ltd. announced that its Chinese subsidiary, Eisai China Inc. (ECI) has commenced full-scale operation of its new Suzhou plant located within the Suzhou Industrial Park, and an opening ceremony was held accordingly. Aiming to further expand its contribution to patients in China, E ... more

Genedata Licenses its Bioprocess Software Platform to Sartorius Stedim Cellca

First-in-class enterprise workflow platform for streamlining cell line development operations

08-Nov-2018 Genedata, a leading provider of advanced software solutions for biopharma R&D, today announced that Sartorius Stedim Cellca GmbH, a subsidiary of Sartorius Stedim Biotech (SSB) and a specialist for cell line development and bioanalytical services for large-scale protein production, has lice ... more

A method to quickly enhance immune-system proteins

07-Nov-2018 Rice University scientists have found a simple method to attach drugs or other substances to antibodies, the powerful proteins that are central to the body's immune system. The Rice lab of bioengineer Han Xiao developed a technique called pClick, which uses a cross-linker that snaps to a sp ... more

Clues to making drugs for "undruggable" targets

07-Nov-2018 Nicolas Thomä's group at the FMI has joined forces with the group of Benjamin Ebert at Harvard’s Broad Institute to show how thalidomide analogs mediate degradation of many more proteins than previously anticipated. These proteins – zinc finger transcription factors – play a role in cancer ... more

All news on pharma

Insect Antibiotic Provides New Way to Eliminate Bacteria

16-Nov-2018 An antibiotic called thanatin attacks the way the outer membrane of Gram-negative bacteria is built. Researchers at the University of Zurich have now found out that this happens through a previously unknown mechanism. Thanatin, produced naturally by the spined soldier bug, can therefore be ... more

Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

Life Science company to develop cancer targeted radiopharmaceuticals

16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

Moths and magnets could save lives

Experimental therapy could repair mutations that cause genetic diseases

15-Nov-2018 A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis. Rice University bioengineer Gang Bao has combined magnetic nanoparticles with a viral container d ... more

"Waltzing" nanoparticles could advance search for better drug delivery methods

"Swirling and spinning" of therapeutic nanoparticles

15-Nov-2018 Indiana University researchers have discovered that drug-delivering nanoparticles attach to their targets differently based upon their position when they meet -- like ballroom dancers who change their moves with the music. The study is significant since the "movement" of therapeutic particl ... more

Stealth-cap technology for light-emitting nanoparticles

14-Nov-2018 A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles. The team has developed the ... more

First microarrayed 3D neuronal culture platform developed

14-Nov-2018 Neuronal development is often regulated by the graded distribution of guidance molecules, which can either attract or repel the neuronal migration or neurite projection when presented in a format of concentration gradients, or chemotaxis. However, many details about the process is largely u ... more

Defective DNA damage repair leads to chaos in the genome

14-Nov-2018 Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now found a cause for the frequent catastrophic events in the genetic material of cancer cells that have only been known for a few years: If an important DNA repair system of the cells has failed, ... more

Poxvirus hijacks cell movement to spread infection

13-Nov-2018 Vaccinia virus, a poxvirus closely related to smallpox and monkeypox, tricks cells it has infected into activating their own cell movement mechanism to rapidly spread the virus in cells and mice, according to a new UCL-led study. The findings explain how the virus mimics infected cells' own ... more

T3 Pharmaceuticals wins prestigious Falling Walls Venture Award

13-Nov-2018 T3 Pharma, a biotech start-up company of the University of Basel with a focus on immuno-oncology, has been named “2018 Science Start-Up of the Year” by Falling Walls Venture. The award honors the scientist-entrepreneurs for their breakthrough business model in bacterial cancer therapy. The ... more

Damage in MS from B cells in meninges

Accumulation of B cells triggers nervous system damage in Multiple Sclerosis

13-Nov-2018 B cells are important in helping the immune system fight pathogens. However, in the case of the neurological autoimmune disease Multiple Sclerosis (MS) they can damage nerve tissue. When particular control cells are missing, too many B cells accumulate in the meninges, resulting in inflamma ... more

All news on healthcare
News by department
  • Products

    Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

    Life Science company to develop cancer targeted radiopharmaceuticals

    16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

    OMEICOS Therapeutics Closes €17m Series C Financing

    Advancing lead candidate towards pivotal trials

    05-Nov-2018 OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, announced the closing of a EUR 17 million (approx. USD 19.5 million) Series C financing led by new ... more

    Milestone Pharmaceuticals Announces $80 Million Private Financing

    30-Oct-2018 Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing interventions for tachycardias,  announced the completion of an $80 million private financing. The equity financing included the support of new and existing institutional investors. Among new investors were RTW Inv ... more

  • Business

    Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

    Life Science company to develop cancer targeted radiopharmaceuticals

    16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

    Grünenthal acquires Averitas Pharma and establishes commercial footprint in the US

    15-Nov-2018 Grünenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza® (8 % capsaicin) for Grünenthal in the US. Grünenthal had only ... more

    Merck has a good third quarter

    Strong organic sales growth impacted by negative exchange rate effects

    14-Nov-2018 Merck generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects. Despite organic growth, EBITDA pre of the Group also declined in comparison with the year-earlier quarter owing to strong negative foreign exchange ef ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Next step on the path towards an efficient biofuel cell

    Two concepts combined making system as efficient as precious metal catalysts

    16-Nov-2018 Fuel cells that work with the enzyme hydrogenase are, in principle, just as efficient as those that contain the expensive precious metal platinum as a catalyst. However, the enzymes need an aqueous environment, which makes it difficult for the starting material for the reaction – hydrogen – ... more

    Insect Antibiotic Provides New Way to Eliminate Bacteria

    16-Nov-2018 An antibiotic called thanatin attacks the way the outer membrane of Gram-negative bacteria is built. Researchers at the University of Zurich have now found out that this happens through a previously unknown mechanism. Thanatin, produced naturally by the spined soldier bug, can therefore be ... more

    Carbon fibers from greenhouse gas

    How algae could sustainably reduce the carbon dioxide concentration in the atmosphere

    16-Nov-2018 In collaboration with fellow researchers, chemists at the Technical University of Munich (TUM) have developed a process that, according to initial calculations, can facilitate economically removing the greenhouse gas carbon dioxide from the atmosphere. The latest World Climate Report (IPCC ... more

  • People

    Abzena invests in expansion of biotherapeutics and makes executive appointment

    07-Nov-2018 Dr. Jonathan Goldman, CEO, announced that Abzena has augmented existing 500 L scale biologics equipment with $20M of investment into two new manufacturing suites at 500 L and 2000 L scale in a new GMP facility in San Diego, which will be equipped with Sartorius single use bioreactors. Abzen ... more

    Merck Presents First Curious Mind Researcher Award

    31-Oct-2018 Merck and the German business journal “manager magazine” presented the Curious Mind Researcher Award for the first time. Barbara Grüner, a medical doctor, received the prize worth € 7,500 in the field of life science. Sascha Fahl, an IT specialist, was recognized with the same prize for his ... more

    Thomas Meier to become new COO of Bachem Group

    29-Oct-2018 Bachem announced that Thomas Meier will succeed Dr. Alex Fässler as Chief Operations Officer of Bachem Group with effect from January 1, 2019. Dr. Alex Fässler will retire at the end of April 2019 yet will continue to serve the company in an advisory capacity. Thomas Meier was born in 1968 ... more

  • Finances

    Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

    Life Science company to develop cancer targeted radiopharmaceuticals

    16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

    Merck has a good third quarter

    Strong organic sales growth impacted by negative exchange rate effects

    14-Nov-2018 Merck generated very strong organic sales growth in the third quarter of 2018. However, this was impacted by negative exchange rate effects. Despite organic growth, EBITDA pre of the Group also declined in comparison with the year-earlier quarter owing to strong negative foreign exchange ef ... more

    Eisai commences full-scale operation of new production site

    Strengthening in-house domestic production system in China

    09-Nov-2018 Eisai Co., Ltd. announced that its Chinese subsidiary, Eisai China Inc. (ECI) has commenced full-scale operation of its new Suzhou plant located within the Suzhou Industrial Park, and an opening ceremony was held accordingly. Aiming to further expand its contribution to patients in China, E ... more

  • Cooperation

    Evotec and Ferring form strategic research alliance

    18-Oct-2018 Evotec AG and Ferring Pharmaceuticalsannounced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions. Evotec will apply its drug discovery platform to design novel, safe and efficacious treatm ... more

    Opening the way for global innovation in biotechnology

    New agreement supports sharing, innovation and openness

    16-Oct-2018 A new easy-to-use legal tool that enables open exchange of biological materials is launched. The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing and innovation in global biotechnology. Material Transfer Agreements (MTAs) provide the legal frameworks with ... more

    Evotec and Celgene expand iPSC collaboration to include additional cell lines

    12-Oct-2018 Evotec AG announced that the Company will receive a $ 6 m payment from Celgene following Celgene’s decision to expand the collaboration to include additional cell lines. Evotec and Celgene initiated the collaboration in December 2016 to identify disease-modifying treatments for a broad rang ... more

  • Technology

    Next step on the path towards an efficient biofuel cell

    Two concepts combined making system as efficient as precious metal catalysts

    16-Nov-2018 Fuel cells that work with the enzyme hydrogenase are, in principle, just as efficient as those that contain the expensive precious metal platinum as a catalyst. However, the enzymes need an aqueous environment, which makes it difficult for the starting material for the reaction – hydrogen – ... more

    Carbon fibers from greenhouse gas

    How algae could sustainably reduce the carbon dioxide concentration in the atmosphere

    16-Nov-2018 In collaboration with fellow researchers, chemists at the Technical University of Munich (TUM) have developed a process that, according to initial calculations, can facilitate economically removing the greenhouse gas carbon dioxide from the atmosphere. The latest World Climate Report (IPCC ... more

    Camel-IDS EUR 37m Series A financing led by V-Bio Ventures

    Life Science company to develop cancer targeted radiopharmaceuticals

    16-Nov-2018 Camel-IDS, a VUB spin-off company developing cancer-targeted radiopharmaceuticals, today secured EUR 37m in a Series A investment round led by V-Bio Ventures (Belgium) and Gimv (Belgium), joined by the co-lead investors HealthCap (Sweden), Novo Seeds (Denmark), Pontifax (Israel) and BioMedP ... more

  • Laws

    Opening the way for global innovation in biotechnology

    New agreement supports sharing, innovation and openness

    16-Oct-2018 A new easy-to-use legal tool that enables open exchange of biological materials is launched. The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing and innovation in global biotechnology. Material Transfer Agreements (MTAs) provide the legal frameworks with ... more

    Recipharm releases first serialised products to Europe

    12-Oct-2018 Recipharm has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros in preparing its facilities for the European Falsified Medicines Directive (EU FMD). The release of its first ... more

    Combined resistance to multiple antibiotics: A growing problem in the EU

    17-Nov-2017 On the occasion of the 10th European Antibiotic Awareness Day, the European Centre for Disease Prevention and Control (ECDC) is releasing its latest EU-wide data on antibiotic resistance, as well as its guidance on prevention and control of carbapenem-resistant Enterobacteriaceae (CRE). In ... more

  • Market

    SOPAT GmbH and Malvern Panalytical announce a distribution agreement for US market

    09-Oct-2018 SOPAT GmbH announced a distribution agreement with Malvern Panalytical. Malvern Panalytical is now the exclusive distributor for a complete range of SOPAT photo-optical image analysis instrumentation and software in the United States of America. “We are thrilled to be working together with ... more

    Catalent Invests $7.3 Million in Italy

    Expands Softgel Encapsulation and Packaging Capabilities in Support of Consumer Health

    08-Oct-2018 Catalent Pharma Solutions announced that it had completed the first phase of a $7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy. The first phase of investment, completed in August 2018, saw the expansion and ... more

    Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)

    14-Sep-2018 For the sixth consecutive year, Abbott has been named the leading company in its industry by the Dow Jones Sustainability Index (DJSI). Abbott is one of the 60 companies recognized for leading their respective global industries. The DJSI designation recognizes companies for responsible and ... more

  • Politics

    15 emerging technologies that could reduce global catastrophic biological risks

    11-Oct-2018 Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Tech ... more

    The starch risk to teeth

    08-Aug-2018 An examination of research on oral health, commissioned by the World Health Organisation, has indicated that for oral health we should stick to whole grain carbohydrates and avoid processed ones, especially if sweet. Food contains different types of starchy carbohydrate with varying degrees ... more

    Multinational companies continue to produce unregulated antibiotics in India

    06-Feb-2018 Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University. The research found that multinational companies continued to manufacture many unapproved formulations, despite pledging to tackle ... more

  • Manufacturing

    Eisai commences full-scale operation of new production site

    Strengthening in-house domestic production system in China

    09-Nov-2018 Eisai Co., Ltd. announced that its Chinese subsidiary, Eisai China Inc. (ECI) has commenced full-scale operation of its new Suzhou plant located within the Suzhou Industrial Park, and an opening ceremony was held accordingly. Aiming to further expand its contribution to patients in China, E ... more

    Genedata Licenses its Bioprocess Software Platform to Sartorius Stedim Cellca

    First-in-class enterprise workflow platform for streamlining cell line development operations

    08-Nov-2018 Genedata, a leading provider of advanced software solutions for biopharma R&D, today announced that Sartorius Stedim Cellca GmbH, a subsidiary of Sartorius Stedim Biotech (SSB) and a specialist for cell line development and bioanalytical services for large-scale protein production, has lice ... more

    Recipharm releases first serialised products to Europe

    12-Oct-2018 Recipharm has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros in preparing its facilities for the European Falsified Medicines Directive (EU FMD). The release of its first ... more

  • Career

    Agilent and University of Duisburg-Essen Announce Collaboration Agreement

    New Teaching and Research Center for Separation

    28-May-2018 Agilent Technologies Inc. and the University of Duisburg-Essen has formed a collaboration agreement that brings together Agilent's leading analytical technologies with the University's outstanding researchers. As part of the collaboration, Agilent will support the university with a broad ra ... more

    Systematic analysis of data from animal models reveals opportunities and limitations

    Professor Malcolm Macleod awarded the BfR’s Maria Sibylla Merian Fellowship

    18-Apr-2018 What opportunities and what limits result from the use of laboratory animals in the preclinical and clinical research? Neurologist Malcolm Macleod has dedicated himself to this topic. For his interdisciplinary research work and his contribution to improving animal welfare, he is awarded thi ... more

    Sartorius Stedim supports biotech training at U Penn

    17-Apr-2018 Sartorius Stedim Biotech andPenn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part o ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE